Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial by Cooper, David A.; Cordery, Damien V.; Zajdenverg, Roberto; Ruxrungtham, Kiat; Arastéh, Keikawus; Bergmann, Frank; Neto, José L. de Andrade; Scherer, Joseph; Chaves, Ricardo L.; Robinson, Patrick; Landay, Alan is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Cooper, David A.; Cordery, Damien V.; Zajdenverg, Roberto; Ruxrungtham, Kiat; Arastéh, Keikawus; Bergmann, Frank; Neto, José L. de Andrade; Scherer, Joseph; Chaves, Ricardo L.; Robinson, Patrick; Landay, Alan
- Publisher
- Public Library of Science; San Francisco CA: Public Library of Science; Publons; ScienceOpen; Public Library of Science (PLoS) (ISSN 1932-6203)
- Published
- 2016
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)